Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever
- PMID: 19112036
- DOI: 10.1016/j.ijid.2008.08.027
Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever
Abstract
Objectives: This study examined the association between lymphocyte subgroups and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF) in Turkey.
Methods: During the spring and summer of 2007, peripheral blood was collected from hospitalized patients with suspected CCHF. Lymphocyte subgroups were characterized by fluorescence-activated cell sorting. CCHF cases were confirmed by detecting viral RNA by PCR and/or IgM antibodies by ELISA. Lymphocyte subgroups were compared between fatal and non-fatal cases. The correlation between lymphocyte subgroups and viral loads was also investigated.
Results: Seventy-seven confirmed cases of CCHF were included in this study (five cases were fatal (6.5 %)). No differences in lymphocyte subgroups were found between fatal and non-fatal cases, except for significantly higher CD3+CD8+ T cells in the fatal cases (p=0.017). A positive correlation between viral load and CD3+CD8+ T cells was also detected (p=0.044). There was no correlation between other lymphocyte subgroups and viral load.
Conclusions: Higher levels of CD3+CD8+ T lymphocytes were detected in fatal compared to non-fatal CCHF cases. Despite this cytotoxic immune activation, a fatal outcome could not be prevented. We hypothesize that high viral load and other factors may influence this outcome, although more studies are required to explain the pathogenesis of CCHF.
Similar articles
-
An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.Int J Infect Dis. 2009 Nov;13(6):e431-6. doi: 10.1016/j.ijid.2009.02.011. Epub 2009 May 5. Int J Infect Dis. 2009. PMID: 19409826
-
Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.J Clin Virol. 2008 Aug;42(4):415-7. doi: 10.1016/j.jcv.2008.03.003. Epub 2008 Apr 22. J Clin Virol. 2008. PMID: 18434247
-
Cytokine levels in Crimean-Congo hemorrhagic fever.J Clin Virol. 2006 Aug;36(4):272-6. doi: 10.1016/j.jcv.2006.04.007. Epub 2006 Jun 9. J Clin Virol. 2006. PMID: 16765637
-
Treatment of Crimean-Congo hemorrhagic fever.Antiviral Res. 2008 Apr;78(1):125-31. doi: 10.1016/j.antiviral.2007.11.002. Epub 2007 Dec 3. Antiviral Res. 2008. PMID: 18096251 Review.
-
Crimean-Congo hemorrhagic fever.Antiviral Res. 2004 Dec;64(3):145-60. doi: 10.1016/j.antiviral.2004.08.001. Antiviral Res. 2004. PMID: 15550268 Review.
Cited by
-
The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Research.Vaccines (Basel). 2020 Feb 22;8(1):98. doi: 10.3390/vaccines8010098. Vaccines (Basel). 2020. PMID: 32098330 Free PMC article. Review.
-
A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.PLoS One. 2014 Mar 12;9(3):e91516. doi: 10.1371/journal.pone.0091516. eCollection 2014. PLoS One. 2014. PMID: 24621656 Free PMC article.
-
Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.J Virol. 2018 Oct 12;92(21):e01083-18. doi: 10.1128/JVI.01083-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30111561 Free PMC article.
-
Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.J Virol. 2019 Aug 28;93(18):e00554-19. doi: 10.1128/JVI.00554-19. Print 2019 Sep 15. J Virol. 2019. PMID: 31292241 Free PMC article.
-
Natural killer cell responses to emerging viruses of zoonotic origin.Curr Opin Virol. 2020 Oct;44:97-111. doi: 10.1016/j.coviro.2020.07.003. Epub 2020 Aug 9. Curr Opin Virol. 2020. PMID: 32784125 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials